26.6 C
New York
Sunday, June 14, 2026

Tag: gut

newssourceFORcompanyinformationcontent1marketreleases

Transforming Long COVID Management: Innovative Telehealth Clinic Offers Unique Approach and Unlocks Hope for Long-Haul COVID Recovery

Struggling with post-COVID symptoms? Access expert-led telehealth support to reclaim your health—limited workshop spots available. DUNEDIN, Fla., June 24, 2025 /PRNewswire/ -- Millions of individuals suffering...

Kefir-Leader Lifeway Foods CEO Julie Smolyansky Honored in Progressive Grocer’s Top Women in Grocery Awards

Industry award recognizes her visionary leadership and significant impact on the functional beverage and wellness sectors MORTON GROVE, Ill., June 24, 2025 /PRNewswire/ -- Lifeway Foods,...

Eshbal Advances North American Growth Strategy with Planned Launch of U.S, Based Manufacturing of Eshbal Pita Bread and Strategic Acquisition

TSXV: ESBL VANCOUVER, BC, June 24, 2025 /CNW/ - Eshbal Functional Food Inc. (TSXV: ESBL) ("Eshbal" or the "Company"), a developer of gluten-free and health-focused food products,...

Pals Health Redefines Supplement Standards with Clinically Proven Ingredients and Exceptional Bioavailability

TOMS RIVER, N.J., June 20, 2025 /PRNewswire/ -- In a supplement market saturated with empty promises and low-quality formulations, Pals Health emerges as a brand committed to...

Glenn Agre Bergman & Fuentes and Public Justice Secure a Preliminary Injunction in High-Profile Pro Bono Case Protecting Student Civil Rights

NEW YORK, June 23, 2025 /PRNewswire/ -- Glenn Agre Bergman & Fuentes has obtained a preliminary injunction in a pro bono lawsuit brought on behalf...

Sakara Enters Clean Beauty Retailer Credo Beauty with New Beauty Biome Supplement

The holistic wellness leader expands its supplement category with new supplement Beauty Biome, now available alongside four other Sakara supplements at all Credo Beauty...

Yili Secures Four World Dairy Innovation Awards at the 18th Global Dairy Congress

AMSTERDAM, June 23, 2025 /PRNewswire/ -- On June 18–19, the Global Dairy Congress 2025 was held in Amsterdam. At the forum, Dr. Ignatius Szeto, Assistant President...

Yili Secures Four World Dairy Innovation Awards at the 18th Global Dairy Congress

AMSTERDAM, June 23, 2025 /PRNewswire/ -- On June 18–19, the Global Dairy Congress 2025 was held in Amsterdam. At the forum, Dr. Ignatius Szeto, Assistant President...

Yili Secures Four World Dairy Innovation Awards at the 18th Global Dairy Congress

AMSTERDAM, June 23, 2025 /CNW/ -- On June 18–19, the Global Dairy Congress 2025 was held in Amsterdam. At the forum, Dr. Ignatius Szeto, Assistant President...

Yili Secures Four World Dairy Innovation Awards at the 18th Global Dairy Congress

AMSTERDAM, June 23, 2025 /PRNewswire/ -- On June 18–19, the Global Dairy Congress 2025 was held in Amsterdam. At the forum, Dr. Ignatius Szeto, Assistant President...

Nixol Capsules Launch in the UK: A Natural Path to Weight Management and Metabolic Support

Nixol introduces a new natural supplement in the United Kingdom to support metabolism, curb cravings, and promote healthy weight loss management using vegan-friendly ingredients. 
Nixol introduces a new natural supplement in the United Kingdom to support metabolism, curb cravings, and promote healthy weight loss management using vegan-friendly ingredients.

MetaVia Presents Pre-Clinical Data on DA-1241 Demonstrating Additive Hepatoprotective Effects in Combination With Efruxifermin at the ADA’s 85th Scientific Session

CAMBRIDGE, Mass., June 21, 2025 /PRNewswire/ -- MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced the presentation of...

Dupixent® (dupilumab) Approved in the U.S. as the Only Targeted Medicine to Treat Patients with Bullous Pemphigoid (BP)

Approval based on pivotal results showing improvements in sustained disease remission and reductions in itch and oral corticosteroid use compared to placebo in adults with BP

Press Release: Dupixent approved in the US as the only targeted medicine to treat patients with bullous pemphigoid

Dupixent approved in the US as the only targeted medicine to treat patients with bullous pemphigoid

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsGut

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers